logo

Atai Life Sciences N.V. (ATAI)



Trade ATAI now with
  Date
  Headline
1/12/2022 7:05:48 AM Atai Life Sciences Announces FDA IND Clearance For PCN-101 R-ketamine Program
12/14/2021 7:40:46 AM Atai Says Positive Topline Data From Phase 2a Study Of RL-007 For Cognitive Impairment Associated With Schizophrenia
8/16/2021 7:24:01 AM Atai Life Sciences Q2 Loss Per Share $0.37 Vs Loss $0.18 Last Year